UW20038
OPEN TO ACCRUAL
PhII Trial of Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients with mCRC
UW23142
OPEN TO ACCRUAL
PII Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for Early Stage Anal Cancer
NRGGI008
OPEN TO ACCRUAL
II/III Study of Colon Adjuvant Chemo Based on Eval of Residual Disease (CIRCULATE-NORTH AMERICA)
UW22112
OPEN TO ACCRUAL
PII of RO7198457 vs watchful waiting in ctDNA+, Resected Stage II (High Risk) & Stage III CRC
EA2222
OPEN TO ACCRUAL
Ph III Study of Systemic Tx +/- Hepatic Arterial Infusion for Unresectable Colorectal Liver Mets
UW22123
OPEN TO ACCRUAL
PH1 Study of Intra-anally Administered Lopinavir/Ritonavir in Subjects with HIV with AIN 2/3
UW24051
OPEN TO ACCRUAL
Phase 1/2 Basket Study of MK-2870 in GI Cancers